Fully immunised ‐ regular immunisation outreach + non‐monetary incentive ( · children under 5 years of age
Immunisation outreach probably leads to higher proportion of children under 5 years of age fully immunised with all… compared with routine care (moderate certainty).
1 finding from 1 review
Proportion of children under 5 years of age fully immunised with all scheduled vaccines · children under 5 years of age
Health education may leads to higher proportion of children under 5 years of age fully immunised with all… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received all recommended vaccines by 2 years of age · children under 5 years of age
Integration of immunisation with other health services may leads to higher proportion of children who received all recommended vaccines by 2… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children under 5 years of age fully immunised with all scheduled vaccines · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drainage pattern ( · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
Neurodevelopmental outcomes · Preterm infants for treatment of RDS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurodevelopmental outcomes · Preterm infants for treatment of RDS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurodevelopmental outcomes · Preterm infants for prevention of RDS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality rate in children < 5 years of age · mothers delivering in the hospitals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality rate in children < 5 years of age · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (three liquid stools in a single day) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Respiratory infections (as measured by trialists) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
All‐cause death (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Diarrhoea (three liquid stools in a single day) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Respiratory infections (as measured by trialists) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
All‐cause death (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Infection or inflammation at individual level as measured by C‐reactive protein (CRP) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Death (between ages 1 and 6 years) · public health programmes to regularly treat all children aged 16 years or less
Multiple doses of deworming drugs showed no clear difference in mortality (between ages 1 and 6 years) compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
CIN3+ associated with HPV16/18 (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years who were HPV16/18 negative before vaccination
The intervention leads to lower CIN3+ associated with HPV16/18 (age 15 to 26 years) (high certainty).
1 finding from 1 review
Intervention not reported
AIS associated with HPV16/18 or 6/11/16/18 (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years who were HPV16/18 negative before vaccination
The intervention probably leads to lower AIS associated with HPV16/18 or 6/11/16/18 (age 15 to 26 years) (moderate certainty).
1 finding from 1 review